| | | |  | Siddhartha Mukherjee and Laura Esserman will discuss the future of cancer treatment, joining more than 30 other high-level speakers at the STAT Summit. Join them there this Nov. 15 and 16, buy your pass here. | | | | By Ed Silverman Adobe "I don’t see any evidence... to justify a 10-fold” price increase, said Stephen Schondelmeyer of the University of Minnesota. Read More | | By Megan Molteni Adobe New RNA-sensing tools could allow scientists to deliver therapeutic payloads, like CRISPR, exclusively to specific types of cells. Read More | | By Daryl Pritchard and Susanne Munksted Adobe The promise of personalized medicine isn't being fully met because of challenges implementing it in clinical practice. Read More | | Sponsored Insight by BIO-RAD LABORATORIES Discover the power of Droplet Digital PCR for hematology-oncology applications For translational and clinical hematology-oncology research, the ability to identify and measure rare nucleic acid sequences is essential. This capability allows reliable detection and monitoring of cancer, even when molecular markers are in very low abundance. Bio-Rad’s proven Droplet Digital PCR HemOnc solutions provide absolute quantification of amplified DNA and RNA with unmatched precision without standard curves. | | By Gwen Nichols Adobe Treatments for pediatric cancer can come at a steep physical and mental cost. Kids need treatments that are less toxic in the long run. Read More | | By Ambar Castillo MacArthur Foundation “What we need to do now is ... understand: Why did [pharma] have this much power in the first place? And patents are the first place to look.” Read More | | By Amanda Krupa and Jill B. Roark and Kirsten Barrett Adobe Website accessibility should be as important to hospitals as accessibility to their buildings. A new study shows it isn't. Read More | |
No comments